ReP USP - Resultado da busca

Filtros : "Clinics and Research in Hepatology and Gastroenterology" Limpar

Filtros

Autores USP
- aguiar, talita ferreira marques (1)
- caires júnior, luiz carlos de (1)
- fernandes, gustavo ribeiro (1)
- krepischi, ana cristina victorino (1)
- lemes, renan barbosa (1)

Colaboração institucional
Afiliação dos autores externos normalizada
Afiliação dos autores externos não normalizada
- department of pediatric oncology, a. c. camargo cancer center, sp (1)
- department of pediatrics, adolescent and child with cancer support group (graacc), federal university of são paulo, sp (1)
- international center for research, a. c. camargo cancer center, sp (1)
- pathology department, rede d’or-são luiz, sp (1)
- research center, boldrini children's hospital, campinas (1)

Artigo de periodico
DNA methylation as a key epigenetic player for hepatoblastoma characterization (2021)
Rivas, Maria; Aguiar, Talita; Fernandes, Gustavo; Lemes, Renan ; Caires-Júnior, Luiz ; Goulart, Ernesto ; Telles-Silva, Kayque; Maschietto, Mariana; Cypriano, Monica ; Toledo, Silvia de; Carraro, Dirce; Cunha, Isabela da; Costa, Cecilia da; Rosenberg, Carla ; Krepischi, Ana Cristina Victorino
Fonte: Clinics and Research in Hepatology and Gastroenterology. Unidades: IB, IQ
Assuntos: METILAÇÃO DE DNA, EXPRESSÃO GÊNICA, NEOPLASIAS HEPÁTICAS, EPIGÊNESE GENÉTICA, CARCINOGÊNESE, CRIANÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIVAS, Maria et al. DNA methylation as a key epigenetic player for hepatoblastoma characterization. Clinics and Research in Hepatology and Gastroenterology, v. 45, n. 3, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.clinre.2021.101684. Acesso em: 24 nov. 2025.
APA
Rivas, M., Aguiar, T., Fernandes, G., Lemes, R., Caires-Júnior, L., Goulart, E., et al. (2021). DNA methylation as a key epigenetic player for hepatoblastoma characterization. Clinics and Research in Hepatology and Gastroenterology, 45( 3). doi:10.1016/j.clinre.2021.101684
NLM
Rivas M, Aguiar T, Fernandes G, Lemes R, Caires-Júnior L, Goulart E, Telles-Silva K, Maschietto M, Cypriano M, Toledo S de, Carraro D, Cunha I da, Costa C da, Rosenberg C, Krepischi ACV. DNA methylation as a key epigenetic player for hepatoblastoma characterization [Internet]. Clinics and Research in Hepatology and Gastroenterology. 2021 ; 45( 3):[citado 2025 nov. 24 ] Available from: https://doi.org/10.1016/j.clinre.2021.101684
Vancouver
Rivas M, Aguiar T, Fernandes G, Lemes R, Caires-Júnior L, Goulart E, Telles-Silva K, Maschietto M, Cypriano M, Toledo S de, Carraro D, Cunha I da, Costa C da, Rosenberg C, Krepischi ACV. DNA methylation as a key epigenetic player for hepatoblastoma characterization [Internet]. Clinics and Research in Hepatology and Gastroenterology. 2021 ; 45( 3):[citado 2025 nov. 24 ] Available from: https://doi.org/10.1016/j.clinre.2021.101684
Artigo de periodico
Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil (2020)
Aguiar, Bruna Forte; Campos, Guilherme Rodrigues Fernandes; Rodrigues, João Paulo Vilela ; Marques, Nayara Nathie; Molina, Bárbara Floriano; Bittar, Cíntia ; Souza, Fernanda Fernandes; Martinelli, Ana de Lourdes Candolo ; Rahal, Paula ; Pereira, Leonardo Régis Leira
Fonte: Clinics and Research in Hepatology and Gastroenterology. Unidades: FMRP, FCFRP
Assuntos: GENÓTIPOS, MUTAÇÃO, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGUIAR, Bruna Forte et al. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil. Clinics and Research in Hepatology and Gastroenterology, v. 44, n. 3, p. 329-339, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clinre.2019.07.015. Acesso em: 24 nov. 2025.
APA
Aguiar, B. F., Campos, G. R. F., Rodrigues, J. P. V., Marques, N. N., Molina, B. F., Bittar, C., et al. (2020). Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil. Clinics and Research in Hepatology and Gastroenterology, 44( 3), 329-339. doi:10.1016/j.clinre.2019.07.015
NLM
Aguiar BF, Campos GRF, Rodrigues JPV, Marques NN, Molina BF, Bittar C, Souza FF, Martinelli A de LC, Rahal P, Pereira LRL. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil [Internet]. Clinics and Research in Hepatology and Gastroenterology. 2020 ; 44( 3): 329-339.[citado 2025 nov. 24 ] Available from: https://doi.org/10.1016/j.clinre.2019.07.015
Vancouver
Aguiar BF, Campos GRF, Rodrigues JPV, Marques NN, Molina BF, Bittar C, Souza FF, Martinelli A de LC, Rahal P, Pereira LRL. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil [Internet]. Clinics and Research in Hepatology and Gastroenterology. 2020 ; 44( 3): 329-339.[citado 2025 nov. 24 ] Available from: https://doi.org/10.1016/j.clinre.2019.07.015

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo 2012 - 2025